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Background: Effective population management of patients with diabetes requires timely recognition. Current
case-finding algorithms can accurately detect patients with diabetes, but lack real-time identification. We sought
to develop and validate an automated, real-time diabetes case-finding algorithm to identify patients with
diabetes at the earliest possible date.
Methods: The source population included 160,872 unique patients from a large public hospital system between
January 2009 and April 2011. A diabetes case-finding algorithm was iteratively derived using chart review and
subsequently validated (n = 343) in a stratified random sample of patients, using data extracted from the
electronic health records (EHR). A point-based algorithm using encounter diagnoses, clinical history, pharmacy
data, and laboratory results was used to identify diabetes cases. The date when accumulated points reached a
specified threshold equated to the diagnosis date. Physician chart review served as the gold standard.
Results: The electronic model had a sensitivity of 97%, specificity of 90%, positive predictive value of 90%, and
negative predictive value of 96% for the identification of patients with diabetes. The kappa score for agreement
between the model and physician for the diagnosis date allowing for a 3-month delay was 0.97, where 78.4% of
cases had exact agreement on the precise date.
Conclusions: A diabetes case-finding algorithm using data exclusively extracted from a comprehensive EHR can
accurately identify patients with diabetes at the earliest possible date within a healthcare system. The real-time
capability may enable proactive disease management.Background
Practice redesign efforts are shifting the paradigm from
volume to value in healthcare in part by emphasizing care
coordination, population health, and performance re-
porting. To this end, the National Committee for Quality
Assurance (NCQA) requires practices to use patient track-
ing, disease registries and certified electronic health re-
cords (EHR) in order to qualify for patient-centered
medical home (PCMH) and accountable care organization
(ACO) accreditation [1,2].
Diabetes is well-suited to the principles of the PCMH
and ACO, given that it affects 25.8 million people, [3] costs* Correspondence: anil.makam@utsouthwestern.edu
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reproduction in any medium, provided the or$174 billion annually, [4] and despite well-established and
effective guidelines only 45% of diabetics receive
recommended care [5,6]. Effective practice redesign efforts
aimed at improving the care of diabetes will require pro-
active identification of patients with diabetes to narrow the
knowledge-to-action gap. While existing diabetes case-
finding algorithms are able to accurately identify patients
with diabetes, [7-17] such algorithms rely on historical ra-
ther than real-time data. As a result, there may be a lag
time between when a patient receives a diagnosis of dia-
betes in the clinical setting compared to when the patient is
identified as a diabetic by a case-finding algorithm for the
purpose of population management. Because preventing
complications of diabetes depends critically on timely inter-
vention, [18] this lag impedes the potential for case-finding
algorithms to significantly affect prevention of such compli-
cations across diabetic populations.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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to date, takes advantage of a comprehensive EHR that
would allow for a fully automated and electronic system
obviating the need for manual data entry, and import-
antly, real-time availability for data capture and identifi-
cation [19]. Therefore, this study aims to derive and
validate an electronic case-finding model (e-model) that
could be used in real-time to identify patients who meet
criteria for diabetes at the earliest possible date based on
EHR data within a healthcare system.
Methods
Study population
The e-model was developed using historical data extracted
from an EHR (Epic Systems Corporation, Verona, WI)
deployed across inpatient and outpatient settings within
Parkland Health & Hospital System (PHHS), a large urban
safety-net health system in Dallas, TX. We used data from
160,872 unique adult patients (age ≥ 18 years) who had a
first encounter within PHHS between January 1, 2009 and
April 1, 2011.
Definition of algorithm variables
To determine the criteria used by the e-model to identify
diabetes, we used a combination of diagnostic criteria
from the American Diabetes Association (ADA) [5] and
data elements identified by a panel of physician health ser-
vice researchers, including a board certified endocrinolo-
gist (AM, CR, RA). Only those data elements which were
routinely documented and extractable from structured
data fields (e.g., encounter diagnosis, past medical history,
problem list, medications, and laboratory results) within
the EHR were included as variables in the e-model.
Derivation of E-model
We used a point-based algorithm to identify the presence
of diabetes and to determine the date that a diagnosis
could have been made through information in the EHR.
Each variable in the e-model was initially assigned a frac-
tional point value, proportionate to its perceived relative
contribution in diagnosing diabetes. Point totals of 0, be-
tween 0 and 1, and ≥ 1 were set as thresholds for e-model
determination of ‘no diabetes,’ ‘possible diabetes,’ and ‘dia-
betes,’ respectively. The e-model determined the diagnosis
date as the date when accumulated points reached or
exceeded a threshold value of 1.
The perceived relative contribution of each variable
was determined based on ADA diagnostic criteria, [5]
existing diabetes case-finding algorithms, [10] and expert
opinion. For example, since the ADA requires two
fasting blood glucose values of ≥ 126 mg/dL for the diag-
nosis of diabetes, the presence of a single fasting blood
glucose value of ≥ 126 mg/dL was assigned a point value
of 0.5, such that two fasting blood glucose values wouldgive an individual a total of 1 point for an e-model iden-
tification of ‘diabetes.’
Point assignments were subsequently recalibrated
through a clinically-guided strategy, consisting of an it-
erative, three-stage evaluation process (Figure 1). At
each stage, a stratified random sample of up to 500
charts, with 50% ‘diabetes,’ 25% ‘possible diabetes,’ and
25% ‘no diabetes’ as determined by the e-model, under-
went unblinded chart review by a physician to evaluate the
accuracy of the e-model identification of diabetes and
diagnosis date. To allow better evaluation of e-model per-
formance, the ‘no diabetes’ group was restricted to individ-
uals 50 years or older since the incidence of diabetes is
strongly associated with age and may increase the poten-
tial to identify false negatives. To allow for evaluation of
the accuracy of the e-model diagnosis date, 50% of the
‘diabetes’ group was selected to have accumulated ≥ 1
point(s) on a date more recent than the date of the first
encounter. This allowed for a potentially earlier date of
diagnosis to be determined by chart review.
Points for individual variables were reweighted after
each stage based on commonly recurring e-model inac-
curacies and were finalized after three successive stages
(Table 1).
Through the derivation process, we adjusted the point
values for diabetes medication, problem list and past med-
ical history, and ICD-9 encounter diagnosis. The presence
of any diabetes medication was initially assigned a point
value of 1, since we considered this a surrogate for the
presence of diabetes given that the primary and often only
indication is the treatment of hyperglycemia. However,
during chart review, metformin was found to be occasion-
ally prescribed for pre-diabetes and polycystic ovarian
syndrome, and individuals with only the presence of met-
formin were incorrectly identified by the e-model as ‘dia-
betes.’ Therefore, the point value for metformin was
decreased to 0.75. The point value for the presence of dia-
betes in the past medical history or problem list fields
were reduced to 0.4 because the data in these fields were
found to be often inaccurate and outdated. Lastly, a single
ICD-9 encounter diagnosis in the absence of other vari-
ables incorrectly identified patients as having diabetes in
most cases. Existing case-finding algorithms have also
found the presence of two ICD-9 codes across outpatient
and inpatient settings to be highly sensitive and more spe-
cific than a single code for the diagnosis of diabetes [20].
Therefore, the encounter diagnosis variable was adjusted
from 1 to 0.75 points.
Validation of E-model
To validate the e-model, we compared the e-model iden-
tification of ‘diabetes,’ ‘possible diabetes’ and ‘no dia-
betes’ and date of diagnosis to the gold standard of





All PHHS adult patients with first encounter between January 1, 2009 and April 1, 2011 
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Physician Review
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Figure 1 Electronic diabetes case-finding model derivation and validation flowchart. * Charts used in derivation were excluded from the
validation cohort.
Makam et al. BMC Medical Informatics and Decision Making 2013, 13:81 Page 3 of 7
http://www.biomedcentral.com/1472-6947/13/81of 70% sensitivity +/− 10% error at a two-sided alpha of
0.05 and power of 80%, we determined that a stratified
random subset of 343 patients (50% ‘diabetes,’ 10% ‘pos-
sible’ diabetes’, and 40% ‘no diabetes’) was needed to ad-
equately validate the e-model. Charts reviewed during
the derivation process were not included in the valid-
ation cohort.Table 1 Variables included in the electronic diabetes case-fin
Identification variable Criteria*
ICD-9 encounter code 250.xx
Hemoglobin A1c ≥ 6.5%
Fasting Blood Glucose ≥ 126 mg/dL
Random blood glucose ≥ 200 mg/dL
2-hour OGTT ≥ 200 mg/dL
Problem list or PMH 250.xx
Diabetes medication** Present
Metformin Present
Abbreviations: ICD-9: International Classification of Diseases 9, OGTT: oral glucose to
*Criteria are counted only once except for ICD-9 codes (maximum twice) and rando
glucose values are ≥ 3 months apart.
**Insulin, sulfonylurea, thiazolidinedione, alpha glucosidase, DPP-4 inhibitor, meglitinBlinded chart review for an initial 50 patients was
completed by two board-certified internists working in-
dependently (AM and ON). Inter-rater agreement be-
tween reviewers for the classification of diabetes status
was 0.80 with a linear weighted kappa statistic and 0.94
for the exact diagnosis date when both reviewers agreed
that diabetes was present (n = 19). The remaining chartsding model
Encounter location Point value
Inpatient or outpatient 0.75
Inpatient or outpatient 1.00
Outpatient only 0.50
Outpatient only 0.50
Inpatient or outpatient 0.75
Inpatient or outpatient 0.40
Outpatient only 1.00
Outpatient only 0.75
lerance test, PMH: past medical history, mg: milligram, dL: deciliter.
m and fasting blood glucose (maximum twice each) as long as repeated
ide, amylin mimetic, incretin mimetic, combination medication.
Table 2 Baseline cohort characteristics for the electronic
diabetes case-finding model*
Characteristics Derivation Validation P-value**
n 1417 341













Encounters, mean no. (SD)
All 7.86 (9.03) 6.65 (9.06) .01
Primary care 2.25 (3.90) 1.99 (3.60) .45
Specialty care 4.31 (6.86) 3.62 (7.08) .02
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equate inter-rater reliability.
To examine model performance, the “possible diabetes”
group was combined with the “no diabetes” group to allow
for a dichotomous classification. Two sensitivity analyses
were performed on the validation cohort to 1) determine
the optimal point threshold for identification of diabetes
and 2) determine the effect of an alternate dichotomous
grouping on e-model performance. For the first sensitivity
analysis, we varied the point threshold for the identifica-
tion of diabetes to test for the optimal cutoff point to
maximize e-model performance. For the second, we
combined the “possible diabetes” group with the “dia-
betes” group to examine the effect on e-model sensitiv-
ity and specificity.
We then evaluated the performance of the e-model
on correct identification of the earliest diagnosis date.
The e-model date was considered to be in agreement
with the physician date of diagnosis if it was within a
3 month window of the physician-determined date. The
time interval of 3 months was chosen based on the
ADA consensus opinion which recommends repeat gly-
cemic testing in 3 months for newly diagnosed or poorly
controlled diabetes patients [5]. Lastly, we compared
the performance of the e-model in identifying the date
of diagnosis to the performance of a simplified claims-
based case-finding algorithm that would not require the
presence of an EHR. This method utilized the presence
of only two diabetes encounter codes (ICD-9 250) to
identify the diagnosis date.
Statistical analysis
The diagnostic performance of the e-model on identifi-
cation of diabetes status was evaluated first by the inter-
rater agreement between e-model classification and
physician classification of diabetes status using the kappa
statistic and second, by using sensitivity, specificity, posi-
tive predictive value (PPV), and negative predictive value
(NPV). The optimal point threshold was evaluated
by the receiver-operator curve. We evaluated the per-
formance of the e-model on correct identification of the
diagnosis date by the inter-rater agreement between the
e-model date of diagnosis and physician determination
of date of diagnosis for individuals identified as ‘diabetes’
by the physician.
Analyses were conducted using STATA statistical soft-
ware (version 12.0; STATA Corp, College Station, TX).
The University of Texas Southwestern Medical Center In-
stitutional Review Board approved the research protocol.Urgent care and ED 0.81 (2.58) 0.61 (0.89) .48
Inpatient 0.49 (0.97) 0.43 (0.88) .25
*Derivation and validation cohorts defined as per Figure 1.
**Student t-test for age; χ2 tests for race/ethnicity, male sex, and primary
payer; Wilcoxon rank-sum test for encounters.Results
Using the e-model to characterize the overall study cohort,
the source population included 14,025 (8.7%) patientsidentified as having ‘diabetes,’ 1,882 (1.2%) patients as
‘possible diabetes,’ and 144,965 (90.1%) patients as ‘no
diabetes.’ In the overall diabetic population (n = 14,205),
the mean age was 52 years (+/− 13 years), 44% were
Hispanic, 27% black, 22% white, 53% male, 68% had a
primary payer of self-pay or charity, and the mean num-
ber of healthcare encounters was 6.5. Of the 1,500
charts for model derivation, 83 were excluded because
of duplicated patients or age less than 18 years. Of the
343 charts for validation, 2 were excluded from analysis
because the chart did not exist (n = 1) or was a duplicate
(n = 1). Patients in the derivation and validation cohorts
were similar with respect to age, race and ethnicity, sex,
and primary payer, but patients in the derivation group
had a slightly greater number of encounters over a one-
year period (Table 2).E-model performance on identification of diabetes
The kappa statistic between the e-model and physician
reviewer on the question of whether diabetes was
present was 0.76 (p < 0.001) with 86% overall agree-
ment. Combining the “possible diabetes” group with
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1 - Specificity
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Figure 2 Receiver operating characteristic curve for the
electronic diabetes case-finding model identification of
diabetes compared to physician review by different point
thresholds (C statistic 0.98).
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of the e-model were 97%, 90%, 89%, and 97% respect-
ively. Alternatively, when the “possible diabetes” group
was combined with the “diabetes” group, the sensitivity
and specificity of the e-model were 99% and 81%
respectively.
The performance of the e-model by different point
thresholds for the identification of diabetes corroborated
using a threshold of 1 point to optimize sensitivity and
specificity (Figure 2).
E-model performance on earliest date of diagnosis
The kappa score between e-model and physician on
the date of diagnosis was 0.94 with agreement on the
exact date in 76% of the cases. Among the cases where
both the physician and e-model made a diagnosis of
diabetes, only 4 observations (2.6%) were diagnosed by
the e-model more than 3 months after the correct date
(Figure 3).
However, a more simplified claims-based algorithm
that used only two ICD-9 encounter diagnoses (e.g. the
diagnosis date equals the date of the second ICD-9
code) did not accurately identify the diagnosis date
compared to a physician reviewer. Using this approach,
the kappa statistic was 0.62 with only 4.6% agreement
on the exact date. Notably, 27% of the cases (n = 33)
did not have a second ICD-9 encounter code during
the study period.
Discussion
We developed an electronic case-finding algorithm that
accurately identified patients with diabetes at their earli-
est possible date within a healthcare system using data
extracted from an EHR. The performance of our model
in identifying patients with diabetes is comparable to
other diabetes case-finding algorithms [10-17]. How-
ever, the distinct advantage of our automated, real-time
algorithm is the timely recognition of diabetes. Relying
on only two ICD-9 encounter codes to establish the
diagnosis date, a quarter of the cases in our cohort
would have been missed and another 11% would have
had a delayed diagnosis. By using multiple data ele-
ments we were able to identify the date of diagnosis
within three months of a physician’s chart review date
in 94% of case, with three-quarters of cases having a
perfect date match.
Achieving early glycemic control in patients with
newly diagnosed diabetes reduces the risk of micro-
vascular complications, myocardial infarction, and all-
cause mortality [18]. Attaining the benefits of instituting
early treatment requires timely diagnosis. In the ARIC
cohort, a population-based prospective study of middle-
aged adults, Samuels et al. found that even with an ef-
fective screening program the median delay from theonset of diabetes to physician diagnosis was 2.4 years,
with more than 7% of incident cases remaining undiag-
nosed for at least 7.5 years [21]. In addition, delayed
diagnoses are more widespread in safety-net settings
where patients may have more fragmented, episodic
care [22]. Real-time, automated patient identification
and tracking can help healthcare systems close this gap
and facilitate the delivery of timely, effective therapy at
the point-of-care at the earliest possible date [19].
Improving care for diabetics is increasingly import-
ant for healthcare systems in today’s pay-for-performance
climate. The high cost, rising prevalence, and documented
quality gap has positioned diabetes in the forefront of pol-
icies benchmarking performance. To qualify for financial
incentives and avoid public scrutiny, healthcare systems
are increasingly faced with the challenge to achieve ac-
ceptable rates in their diabetic population for targeted
metrics such as glycated hemoglobin, low-density lipopro-
tein, and screening for microalbuminuria. Our electronic
case-finding algorithm, which leverages real-time data
in the EHR, can enable proactive management of these
quality measures. Healthcare systems may additionally
apply this algorithm to provide feedback to providers
on the quality of their care, generate letters to pa-
tients, identify underperforming clinics for quality im-
provement initiatives, link clinical decision support
tools to inform decision making at the point-of-care,
and risk stratify diabetic patients to direct limited re-
sources to patients at greatest risk for developing
complications.
Our study has several limitations. First, as with other
registries, the limitations of miscoding and misclassifica-
tion prohibited subtype distinction between type 1, type
2, and secondary diabetes [23]. Second, due to limits in
study costs, we established an enriched prevalence of
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Figure 3 Comparison of the date of diagnosis of diabetes within a healthcare system as ascertained by the electronic diabetes
case-finding model and physician reviewer. Observations below and to the right of the dashed line (shaded area) are within the allowed
3-month window for agreement.
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While this inflated the positive and negative predictive
values, the sensitivity and specificity of our algorithm
remained unaffected and were comparable to other
diabetes case-finding algorithms. Third, by using the
e-model algorithm to select our validation cohort, we
were unable to evaluate how individual data elements
performed in identifying diabetes. Fourth, the direct
applicability of our algorithm to other settings is un-
known because of differences in practice style, EHR in-
tegration across outpatient and inpatient settings, and
EHR documentation. Systems with greater accuracy in
EHR documentation may need to increase the relative
weight of the problem list and past medical history
field to maximize the model’s performance. With
proper weight adjustments we expect our algorithm to
be suitable to a wide range of healthcare settings. Au-
tomated machine learning techniques may provide ap-
proaches to model adjustment that could minimize
manual recalibration and allow larger scales of dissem-
ination. Lastly, in clinical settings transitioning from
paper-based records to an EHR, the e-model may not
accurately distinguish between newly established ver-
sus preexisting cases of diabetes within a healthcare
system [24].Conclusion
Our electronic case-finding algorithm can accurately iden-
tify patients with diabetes at the earliest possible date
within a healthcare system. We believe this algorithm can
be used by healthcare systems with comprehensive EHRsto build real-time diabetes identification systems. This is
foundational to diabetes “system awareness,” or building
information systems that are able to construct and main-
tain awareness of a patient’s status across time, setting,
provider, and context.Competing interests
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